Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Adenocarcinoma
×
pembrolizumab
×
Clear all
Filters
3
NCT06901531
2026-03-11
LUCERNA
Astellas Pharma Inc
Phase 3
Recruiting
500 enrolled
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts